{"id":25410,"date":"2023-01-06T07:03:45","date_gmt":"2023-01-06T12:03:45","guid":{"rendered":"https:\/\/www.ipoboutique.com\/blog\/?p=25410"},"modified":"2023-01-06T07:04:10","modified_gmt":"2023-01-06T12:04:10","slug":"ipo-pipeline-update-skyward-sets-terms-large-deal-looms-for-end-of-january","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-pipeline-update-skyward-sets-terms-large-deal-looms-for-end-of-january\/","title":{"rendered":"IPO Pipeline Update: Skyward Sets Terms, Large Deal Looms for End of January"},"content":{"rendered":"<p><!--more--><strong>NEW FILINGS<\/strong><br \/>\nCompany: Kenvue Inc.<br \/>\nSymbol: KVUE (NYSE)<br \/>\nDescription: They are the world\u2019s largest pure-play consumer health company by revenue with $15.1 billion in net sales in 2021.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\n<a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1944048\/000162828023000234\/kenvues-1.htm#ia874ee9d717e4fefb8e6cba9cd33edb0_451\"><strong>Underwriters: Goldman Sachs, J.P. Morgan<\/strong><\/a><br \/>\n<a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1944048\/000162828023000234\/kenvues-1.htm#ia874ee9d717e4fefb8e6cba9cd33edb0_451\"><strong>Link to Prospectus: Filed 1-4-23<\/strong><\/a><\/p>\n<p><strong>TERMS ADDED<\/strong><\/p>\n<p>Company: Skyward Specialty Insurance Group, Inc.<br \/>\nSymbol: SKWD (Nasdaq)<br \/>\nDescription: They are a growing specialty insurance company delivering commercial property and casualty (\u201cP&amp;C\u201d) products and solutions on a non-admitted (or excess and surplus (\u201cE&amp;S\u201d)) and admitted basis, predominantly in the United States.<br \/>\nShares: 8.5 million<br \/>\nPrice Range: $14.00-$16.00<br \/>\nMarket Cap: $530m-$600m<br \/>\nTrade Date: Friday, 1\/13<br \/>\nUnderwriters: Barclays, Keefe Bruyette &amp; Woods, Piper Sandler, JMP Securities, Truist Securities, Raymond James<br \/>\nCo-Manager(s): Academy Securities, Siebert Williams Shank<br \/>\n<a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1519449\/000110465923000600\/tm228594-15_s1a.htm\"><strong>Link to Prospectus: Terms Added: 1-4-23<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":null,"zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":null,"zakra_breadcrumbs_separator_color":null,"zakra_breadcrumbs_link_color":null,"zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[1536],"tags":[],"class_list":["post-25410","post","type-post","status-publish","format-standard","hentry","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/25410","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=25410"}],"version-history":[{"count":2,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/25410\/revisions"}],"predecessor-version":[{"id":25412,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/25410\/revisions\/25412"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=25410"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=25410"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=25410"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}